An interventional study of Larynx Allograft Transplantation in Larynx Stenosis, Larynx Disease and Laryngectomy, sponsored by Mayo Clinic. Suspended at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-22.
Sponsored by Mayo Clinic · Not applicable, Interventional, and Treatment
The purpose of this proposed study is to obtain safety and efficacy data on human laryngeal allograft transplantation in an effort to safely use these procedures as a viable reconstructive option for patients with severe laryngeal or laryngotracheal incompetence.
Patients with severe laryngeal or laryngotracheal incompetence without other reconstructive options will be considered for cadaveric laryngotracheal transplantation. Data will be collected from 10 patients and will include length of hospital stay, short-term complications, long-term complications, hospital readmission, return trips to the operating room (OR), rejection episodes and severity, swallowing function, ability to have tracheotomy tube decannulated, voice parameters, pulmonary function, development of anti-donor antibodies, and quality of life scores.
Potential subjects for this study include patients with severe laryngeal dysfunction or a previous laryngectomy. For the purposes of this study, severe laryngeal dysfunction is defined as the loss of normal laryngeal function resulting in significant dysphonia, dysphagia, or dyspnea.
Inclusion Criteria:
One of the following:
Exclusion Criteria:
Poor surgical candidacy secondary to poor physical/mental health as determined by a pre-operative medical evaluation
General medical status
Any systemic disease which would alter life expectancy
Psychosocial parameters
Cadaveric laryngotracheal transplantation
Procedure: Larynx Allograft Transplantation
This study is a prospective clinical trial designed to assess the efficacy and safety of laryngeal transplantation. A total of 10 patients will be enrolled over a five-year timeframe. Study length is 5 years.
Survival of the allograft at the one-year visit.
Survival of the allograft as indicated by histological rejection grading.
Time frame: 1 year
Swallowing without aspiration at the one-year visit.
Time frame: 1 year
Voice Evaluation
Standard voice evaluation will include voice recordings, acoustic and aerodynamic measurements as compared to baseline measurements.
Time frame: 1 year
Pulmonary function
Pulmonary function values within normal range.
Time frame: 1 year
Ability to have tracheotomy tube decannulated
Ability to have tracheotomy tube decannulated after successful capping trials.
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
This study is suspended, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Laryngostenosis
Mayo Clinic